fluconazole has been researched along with Vaginal Diseases in 7 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Vaginal Diseases: Pathological processes of the VAGINA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fluconazole is a bis-triazole antifungal drug which has a pharmacokinetic profile characterised by its high water solubility, low affinity for plasma proteins, and metabolic stability." | 6.39 | Fluconazole. An update of its antimicrobial activity, pharmacokinetic properties, and therapeutic use in vaginal candidiasis. ( McTavish, D; Perry, CM; Whittington, R, 1995) |
| "Fluconazole is a bis-triazole antifungal drug which has a pharmacokinetic profile characterised by its high water solubility, low affinity for plasma proteins, and metabolic stability." | 2.39 | Fluconazole. An update of its antimicrobial activity, pharmacokinetic properties, and therapeutic use in vaginal candidiasis. ( McTavish, D; Perry, CM; Whittington, R, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yao, B | 1 |
| Ji, H | 1 |
| Cao, Y | 1 |
| Zhou, Y | 1 |
| Zhu, J | 1 |
| Lü, J | 1 |
| Li, Y | 1 |
| Chen, J | 1 |
| Zheng, C | 1 |
| Jiang, Y | 1 |
| Liang, R | 1 |
| Tang, H | 1 |
| Villagrana-Zesati, JR | 1 |
| Guerra-Infante, FM | 1 |
| Sosa-González, IE | 1 |
| Sharma, R | 1 |
| Garg, T | 1 |
| Goyal, AK | 1 |
| Rath, G | 1 |
| Zhang, JD | 1 |
| Cao, YB | 1 |
| Xu, Z | 1 |
| Sun, HH | 1 |
| An, MM | 1 |
| Yan, L | 1 |
| Chen, HS | 1 |
| Gao, PH | 1 |
| Wang, Y | 1 |
| Jia, XM | 1 |
| Jiang, YY | 1 |
| Perry, CM | 1 |
| Whittington, R | 1 |
| McTavish, D | 1 |
| Chen, CK | 1 |
| Chang, DY | 1 |
| Chang, SC | 1 |
| Lee, EF | 1 |
| Huang, SC | 1 |
| Chow, SN | 1 |
1 review available for fluconazole and Vaginal Diseases
| Article | Year |
|---|---|
Fluconazole. An update of its antimicrobial activity, pharmacokinetic properties, and therapeutic use in vaginal candidiasis.
Topics: Administration, Oral; Anti-Bacterial Agents; Azoles; Candidiasis; Drug Interactions; Female; Flucona | 1995 |
1 trial available for fluconazole and Vaginal Diseases
| Article | Year |
|---|---|
[Clinical efficacy of fluconazole, tinidazole and clindamycin vs fluconazole, tinidazole and azithromycin in the treatment of mixed cervical-vaginal infections, included those caused by Mycoplasma and Chlamydia trachomatis].
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Antitrichomonal Agents; Azithromycin; Chlamydia Inf | 2013 |
5 other studies available for fluconazole and Vaginal Diseases
| Article | Year |
|---|---|
Synthesis and antifungal activities of novel 2-aminotetralin derivatives.
Topics: Administration, Intravaginal; Animals; Antifungal Agents; Binding Sites; Candida albicans; Candidias | 2007 |
Development, optimization and evaluation of polymeric electrospun nanofiber: A tool for local delivery of fluconazole for management of vaginal candidiasis.
Topics: Adhesiveness; Anti-Bacterial Agents; Candida albicans; Candidiasis; Chemistry, Pharmaceutical; Drug | 2016 |
In vitro and in vivo antifungal activities of the eight steroid saponins from Tribulus terrestris L. with potent activity against fluconazole-resistant fungal pathogens.
Topics: Animals; Antifungal Agents; Candida; Cryptococcus neoformans; Disease Models, Animal; Drug Resistanc | 2005 |
Cryptococcal infection of the vagina.
Topics: Aged; Biopsy; Cryptococcosis; Female; Fluconazole; Humans; Vagina; Vaginal Diseases | 1993 |
[Systematic therapy of vaginal mycoses. Three quarters of women are affected].
Topics: Antifungal Agents; Candidiasis; Female; Fluconazole; Humans; Itraconazole; Mycoses; Vaginal Diseases | 1994 |